Page last updated: 2024-08-21

benzoxazoles and Cardiomyopathies

benzoxazoles has been researched along with Cardiomyopathies in 67 studies

Research

Studies (67)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	22 (32.84)	24.3611
2020's	45 (67.16)	2.80

Authors

Authors	Studies
Damy, T; Grogan, M; Gundapaneni, B; Hanna, M; Maurer, MS; Stewart, M; Sultan, MB	1
Beitzke, D; Binder, C; Bonderman, D; Charwat-Resl, S; Dachs, TM; Dalos, D; Donà, C; Duca, F; Eslam, RB; Hengstenberg, C; Kammerlander, A; Kastner, J; Koschutnik, M; Ligios, LC; Loewe, C; Mann, C; Rettl, R; Schrutka, L	1
Drachman, BM; Ebede, B; Elliott, P; Gottlieb, SS; Gundapaneni, B; Hoffman, JE; Hummel, SL; Lenihan, DJ; Li, B; Shah, SJ; Sultan, MB	2
Brogneaux, C; Grayet, D; Jackers, L; Lacremans, D; Legrand, D; Magnée, M; Nyssen, A; Pirotte, I	1
Asaji, M; Chang, J; Higo, T; Ide, S; Inui, H; Kamada, Y; Kanno, K; Koseki, M; Nishida, M; Ohama, T; Okada, T; Okuzaki, D; Ono, M; Saga, A; Saibara, T; Saito, S; Sakata, Y; Tanaka, K; Yamashita, S; Zhu, Y	1
Bhambri, R; Nativi-Nicolau, J; Rozenbaum, MH; Tran, D	1
Aguirre, MA; Baratta, S; Belziti, CA; Carretero, M; Costabel, JP; Dumont, CA; Fernández, A; Higa, C; Negro, A; Nucifora, EM; Perez de Arenaza, D; Posadas-Martínez, ML; Quiroga, A; Rivas, C; Streitenberg, GM; Villanueva, E; Volberg, VI	1
Baba, Y; Hamada, T; Hirota, T; Kitaoka, H; Kubo, T; Miyagawa, K; Noguchi, T; Ochi, Y; Sugiura, K; Yamasaki, N	1
Gomez-Valencia, J; Malhotra, S; Mekritthikrai, R	1
Elliott, P; Gundapaneni, B; Sultan, MB	1
Baldovino, S; Costanzo, P; Roccatello, D	1
Cuddy, SAM	1
Casey, M; Li, H; Rozenbaum, M; Sultan, MB	1
Hori, M; Imamura, T; Izumida, T; Kinugawa, K; Tanaka, S	1
Mitchell, JD; Rater, M; Schiffer, W; Zaghlol, R	1
Balasubramanian, SS; Gaznabi, S; Hussain, K; Iqbal, SH; Kwak, E; Macrinici, V; Minga, I; Pursnani, A; Sarswat, N; Wang, CH; Wathen, L	1
Bulawa, C; Fleming, J; Li, Z; Maurer, TS; Moody, AT; Tess, DA	1
Coelho, T; Jaeger, M; Kelly, JW; Powers, ET; Tsai, FJ	1
Czepluch, F	1
Ando, Y; Endo, J; Fukuda, K; Inomata, T; Isobe, M; Izumiya, Y; Kuwahara, K; Nakamura, K; Sano, M; Sekijima, Y; Tahara, N; Tsujita, K; Tsutsui, H; Ueda, M	1
Paton, DM	1
Maurer, MS; Rubin, J	1
Arnold, SV; Baron, SJ; Bellows, BK; Cohen, DJ; Kazi, DS; Maurer, MS; Shah, SJ; Shen, C; Sperry, BW; Spertus, JA; Yeh, RW	2
Le, VH; Lockwood, PA; O'Gorman, MT; Patterson, TA; Riley, S; Sultan, MB; Tankisheva, E; Wang, Q	1
Hlatky, MA	1
Kelly, JW; Nelson, LT; Paxman, RJ; Powers, ET; Webb, B; Xu, J	1
Audia, S; Damy, T; Eicher, JC	1
Amano, M; Ando, Y; Anzai, T; Baba, Y; Endo, J; Fukuda, K; Inomata, T; Isobe, M; Izumi, C; Izumiya, Y; Kimura, T; Kitaoka, H; Koyama, J; Kubo, T; Misumi, Y; Oda, S; Okada, A; Sano, M; Sekijima, Y; Tahara, N; Takashio, S; Tomita, T; Tsujita, K; Tsukada, N; Tsutsui, H; Ueda, M; Yazaki, M	1
Almeida, AR; Azevedo, O; Bento, D; Correia, E; Cruz, I; Lopes, LR; Lourenço, C; Marques, N	1
Kemner, J; Parasuraman, B; Rozenbaum, MH	1
Damy, T; Garcia-Pavia, P; Gundapaneni, B; Hanna, M; Judge, DP; Merlini, G; Patterson, TA; Riley, S; Schwartz, JH; Sultan, MB; Witteles, R	1
Dobner, S	1
Damy, T; Grogan, M; Gundapaneni, B; Hanna, M; Maurer, MS; Patterson, TA; Schwartz, JH; Stewart, M; Sultan, MB	1
Berk, JL; Boman, K; Damy, T; Elliott, P; Gundapaneni, B; Maurer, MS; Nativi-Nicolau, J; Patterson, TA; Rapezzi, C; Schwartz, JH; Sultan, MB; Velazquez, EJ	1
Damy, T; Sultan, MB; Witteles, R	1
Psotka, MA	1
Aimo, A; Emdin, M; Rapezzi, C	1
Lamb, YN	1
Benbrahim, M; Hughes, D; Norman, K; Sanchorawala, V; Siddiqi, OK	1
Gundapaneni, B; Januzzi, JL; López-Sendón, J; Miller, AB; O'Neill, BJ; Patterson, TA; Sultan, MB	1
Kittleson, MM; Stern, LK	1
Boucher, M; Harnisch, LO; Riley, S; Vong, C	1
Bhambri, R; Garcia, A; Grima, D; Heeg, B; Li, B; Masri, A; Postma, M; Rozenbaum, MH; Stewart, M; Tran, D	1
Griffin, JM; Maurer, MS; Rosenblum, H	1
Cruz, MW; Elliott, P; Flynn, A; Gundapaneni, B; Hahn, C; Maurer, MS; Merlini, G; Rapezzi, C; Riley, S; Schwartz, J; Shah, SJ; Sultan, MB	1
Kristen, AV	1
Barsdorf, AI; Damy, T; Drachman, BM; Elliott, PM; Grogan, M; Gundapaneni, B; Hanna, M; Huber, P; Judge, DP; Kristen, AV; Maurer, MS; Merlini, G; Patterson, TA; Rapezzi, C; Riley, S; Schumacher, J; Schwartz, JH; Shah, SJ; Stewart, M; Sultan, MB; Waddington-Cruz, M; Witteles, R	1
Ando, Y; Ikeda, N; Kato, TS; Maurer, MS; Tanno, K	1
Le Bras, A	1
Barreira, AA; Bulle, AS; França, MC; Freitas, MRG; Gondim, FAA; Marques, W; Marrone, CD; Nascimento, OJM; Pinto, MV; Pupe, C; Rotta, FT; Waddington-Cruz, M	1
Amaki, M; Amano, M; Hamatani, Y; Hasegawa, T; Ishibashi-Ueda, H; Izumi, C; Kanzaki, H; Morita, Y; Ohta-Ogo, K; Okada, A; Sekijima, Y; Shimazaki, C; Shintani, Y; Takahama, H; Yasuda, S; Yazaki, M; Yoshinaga, T	1
Ando, Y; Hashimoto, T; Hiroe, M; Kawamura, S; Yamamoto, H; Yamashita, T; Yokochi, T	1
Maurer, MS; Rapezzi, C; Sultan, MB	1
Manion, C; Sharma, UC	1
Falk, RH	1
Abate, E; Ali, M; Bigalke, B; de Vecchis, R; Mammadov, M; Matiakis, M; Mavrogeni, S; Melnyk, H; Noutsias, M; Rigopoulos, AG; Torky, AR; Vogt, A; Wohlgemuth, W	1
Bokhari, S; Damy, T; Elliott, PM; Falk, RH; Fine, NM; Garcia-Pavia, P; Gospodinova, M; Obici, L; Rapezzi, C; Witteles, RM	1
Autore, C; Canepa, M; Cappelli, F; Milandri, A; Mussinelli, R; Musumeci, B; Perfetto, F; Perlini, S; Rapezzi, C; Tini, G	1
Alhamadsheh, MM; Baranczak, A; Chan, WK; Connelly, S; Graef, IA; Kelly, JW; Liedtke, M; Park, MS; Penchala, SC; Powers, ET; Rappley, I; Reixach, N; Vogel, H; Wang, Y; Wilson, IA; Witteles, RM; Zhao, L	1
Cao, Y; Dulce, RA; Gonzalez, DR; Hare, JM; Lamirault, G; Mayo, V; Treuer, AV	1
Castaño, A; Drachman, BM; Judge, D; Maurer, MS	1
Aarts, J; Berthet, K; Damy, T; Judge, DP; Kristen, AV; Li, H	1
Aarts, J; Falk, RH; Grogan, DR; Judge, DP; Lombardo, I; Maurer, MS; Mundayat, R; Packman, J; Quyyumi, AA	1
Baranczak, A; Cho, Y; Helmke, S; Horn, EM; Kelly, JW; Maurer, MS; Teruya, S	1

Reviews

15 review(s) available for benzoxazoles and Cardiomyopathies

Article	Year
[Diagnosis and treatment of cardiac transthyretin amyloidosis. Innovative therapy with tafamidis.] Revue medicale de Liege, 2022, Volume: 77, Issue:1 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Humans; Therapies, Investigational	2022
Impact of Tafamidis on Survival in a Real-World Community-Based Cohort. Current problems in cardiology, 2022, Volume: 47, Issue:12 Topics: Aged, 80 and over; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Female; Heart Failure; Humans; Male; Observational Studies as Topic; Prospective Studies	2022
Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language Summary. Future cardiology, 2023, Volume: 19, Issue:1 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Humans; Prealbumin	2023
[Transthyretin amyloid cardiomyopathy]. Innere Medizin (Heidelberg, Germany), 2023, Volume: 64, Issue:9 Topics: Aged; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin; Stroke Volume; Tomography, X-Ray Computed	2023
Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable. Annual review of medicine, 2020, 01-27, Volume: 71 Topics: Amyloid Neuropathies, Familial; Amyloidosis; Arrhythmias, Cardiac; Benzoates; Benzoxazoles; Biopsy; Cardiac Pacing, Artificial; Cardiomyopathies; Diflunisal; Disease Progression; Early Diagnosis; Early Medical Intervention; Echocardiography; Electrocardiography; Heart Failure; Humans; Immunoglobulin Light-chain Amyloidosis; Immunologic Factors; Magnetic Resonance Imaging; Oligonucleotides; Prealbumin; Prognosis; Proteasome Inhibitors; Pyrazoles; Radionuclide Imaging; RNA, Small Interfering	2020
[Transthyretin cardiac amyloidosis]. La Revue de medecine interne, 2020, Volume: 41, Issue:10 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Echocardiography; Electrocardiography; Humans	2020
Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence-Based Recommendations. Journal of the American Heart Association, 2020, 10-20, Volume: 9, Issue:19 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Cardiovascular Agents; Genetic Therapy; Humans	2020
Tafamidis: A Review in Transthyretin Amyloid Cardiomyopathy. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021, Volume: 21, Issue:1 Topics: Amyloidogenic Proteins; Benzoxazoles; Cardiomyopathies; Double-Blind Method; Hospitalization; Humans; Multicenter Studies as Topic; Prealbumin; Quality of Life; Randomized Controlled Trials as Topic; Walk Test	2021
A Review of Novel Agents and Clinical Considerations in Patients With ATTR Cardiac Amyloidosis. Journal of cardiovascular pharmacology, 2021, 05-01, Volume: 77, Issue:5 Topics: Amyloid Neuropathies, Familial; Animals; Benzoxazoles; Cardiomyopathies; Cardiovascular Agents; Diflunisal; Genetic Predisposition to Disease; Humans; Mutation; Oligonucleotides; Phenotype; Prealbumin; RNA, Small Interfering; Treatment Outcome	2021
Updates in Cardiac Amyloidosis Diagnosis and Treatment. Current oncology reports, 2021, 03-16, Volume: 23, Issue:4 Topics: Amyloid Neuropathies, Familial; Amyloidosis; Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Immunoglobulin Light-chain Amyloidosis	2021
Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis. Circulation research, 2021, 05-14, Volume: 128, Issue:10 Topics: Aging; Alkylating Agents; Amyloid; Amyloid Neuropathies, Familial; Amyloidosis; Antibodies, Monoclonal; Benzoates; Benzoxazoles; Bridged Bicyclo Compounds, Heterocyclic; Cardiomyopathies; Catechol O-Methyltransferase Inhibitors; Heart Transplantation; Humans; Immunomodulating Agents; Oligonucleotides; Proteasome Inhibitors; Protein Folding; Pyrazoles; RNA, Small Interfering; Stem Cell Transplantation; Sulfonamides; Tolcapone	2021
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial). Circulation. Heart failure, 2017, Volume: 10, Issue:6 Topics: Administration, Oral; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Clinical Trials, Phase III as Topic; Disease Management; Disease Progression; Humans; Randomized Controlled Trials as Topic	2017
Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement. Heart failure reviews, 2019, Volume: 24, Issue:4 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Biomarkers; Cardiomyopathies; Diagnosis, Differential; Echocardiography; Electrocardiography; Humans; Magnetic Resonance Imaging; Oligonucleotides; Radionuclide Imaging; RNA, Small Interfering	2019
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. JACC. Heart failure, 2019, Volume: 7, Issue:8 Topics: Age Factors; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Delayed Diagnosis; Diagnostic Errors; Early Diagnosis; Early Medical Intervention; Heart Failure; Humans; Stroke Volume	2019
Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. Heart failure reviews, 2015, Volume: 20, Issue:2 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Biomarkers; Cardiomyopathies; Cyclooxygenase Inhibitors; Defibrillators, Implantable; Diflunisal; Doxycycline; Heart Failure; Humans; Oligonucleotides, Antisense; Organ Transplantation; Pacemaker, Artificial; RNA, Small Interfering	2015

Trials

11 trial(s) available for benzoxazoles and Cardiomyopathies

Article	Year
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022, Volume: 22, Issue:4 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Hospitalization; Humans; Prealbumin	2022
Estimating the Effect of Tafamidis on Cardiovascular-Related Hospitalization in NYHA Class III Patients with Transthyretin Amyloid Cardiomyopathy in the Presence of Death. Cardiology, 2022, Volume: 147, Issue:4 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Hospitalization; Humans; Prealbumin	2022
The Bioequivalence of Tafamidis 61-mg Free Acid Capsules and Tafamidis Meglumine 4 × 20-mg Capsules in Healthy Volunteers. Clinical pharmacology in drug development, 2020, Volume: 9, Issue:7 Topics: Administration, Oral; Adult; Amyloid Neuropathies; Amyloid Neuropathies, Familial; Benzoxazoles; Brazil; Canada; Cardiomyopathies; Cross-Over Studies; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Compounding; Fasting; Female; Healthy Volunteers; Humans; Japan; Male; Middle Aged; Prealbumin; Safety; Therapeutic Equivalency; United States	2020
Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study. European journal of heart failure, 2021, Volume: 23, Issue:2 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin	2021
Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial). The American journal of cardiology, 2021, 02-15, Volume: 141 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Cost of Illness; Female; Humans; Male; Patient Reported Outcome Measures; Quality of Life; Self Efficacy; Social Participation	2021
Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT]). The American journal of cardiology, 2021, 06-01, Volume: 148 Topics: Aged; Amyloid Neuropathies, Familial; Amyloidosis; Arrhythmias, Cardiac; Benzoxazoles; Cardiomyopathies; Cardiovascular Diseases; Cause of Death; Death, Sudden, Cardiac; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Prealbumin; Proportional Hazards Models; Stroke	2021
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies. European heart journal. Quality of care & clinical outcomes, 2022, 08-17, Volume: 8, Issue:5 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Humans; Prealbumin	2022
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. The New England journal of medicine, 2018, Sep-13, Volume: 379, Issue:11 Topics: Administration, Oral; Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Disease Progression; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Prealbumin; Quality of Life; Survival Analysis; Walk Test	2018
Tafamidis for transthyretin amyloid cardiomyopathy: the solution or just the beginning of the end? European heart journal, 2019, 03-21, Volume: 40, Issue:12 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Case-Control Studies; Echocardiography; Hospitalization; Humans; Mutation; Placebos; Prealbumin; Survival Analysis	2019
Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis. Journal of cardiovascular translational research, 2015, Volume: 8, Issue:2 Topics: Adult; Aged; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Europe; Female; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Humans; Male; Middle Aged; Mutation; Myocardium; Phenotype; Prealbumin; Risk Factors; Time Factors; Treatment Outcome; United States	2015
Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes. Circulation. Heart failure, 2015, Volume: 8, Issue:3 Topics: Aged; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Disease Progression; Drug Administration Schedule; Female; Humans; Male; Mutation; Myocardium; Prealbumin; Protein Folding; Protein Multimerization; Protein Stability; Protein Structure, Quaternary; Time Factors; Treatment Outcome; United States	2015

Other Studies

41 other study(ies) available for benzoxazoles and Cardiomyopathies

Article	Year
Tafamidis and quality of life in people with transthyretin amyloid cardiomyopathy in the study ATTR-ACT: A plain language summary. Future cardiology, 2022, Volume: 18, Issue:3 Topics: Adult; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Language; Prealbumin; Quality of Life	2022
Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy. European heart journal. Cardiovascular Imaging, 2022, 06-01, Volume: 23, Issue:6 Topics: Amyloidosis; Benzoxazoles; Cardiomyopathies; Heart Ventricles; Humans; Prealbumin; Time-to-Treatment	2022
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy. Circulation. Heart failure, 2022, Volume: 15, Issue:1 Topics: Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Prealbumin; Proportional Hazards Models; Time	2022
Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy. Scientific reports, 2022, 02-22, Volume: 12, Issue:1 Topics: Animals; Benzoxazoles; Butyrates; Cardiomyopathies; Diet, High-Fat; Dietary Carbohydrates; Disease Models, Animal; Gene Expression; Inflammasomes; Liver; Male; Mice, Inbred C57BL; Myocardium; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease	2022
[Specific pharmacological treatment guide for transthyretin amyloid cardiomyopathy, 2021]. Medicina, 2022, Volume: 82, Issue:2 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Diflunisal; Doxycycline; Humans; Prealbumin; Ursodeoxycholic Acid	2022
Early Experience of Tafamidis Treatment in Japanese Patients With Wild-Type Transthyretin Cardiac Amyloidosis From the Kochi Amyloidosis Cohort. Circulation journal : official journal of the Japanese Circulation Society, 2022, 06-24, Volume: 86, Issue:7 Topics: Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Humans; Japan; Prealbumin; Stroke Volume; Ventricular Function, Left	2022
What is this image? 2022 image 1 result: radiologic improvement of transthyretin cardiac amyloidosis after treatment with tafamidis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:4 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Humans; Prealbumin	2022
Response by Elliott et al to Letter Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy". Circulation. Heart failure, 2022, Volume: 15, Issue:7 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin	2022
Letter by Baldovino et al Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy". Circulation. Heart failure, 2022, Volume: 15, Issue:7 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin	2022
Understanding Changes in Functional Capacity After TTR Stabilization in Patients With Transthyretin Cardiac Amyloidosis. Circulation. Heart failure, 2022, Volume: 15, Issue:7 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin	2022
Combination therapy using tafamidis and neurohormonal blockers for cardiac amyloidosis and a reduced ejection fraction: a case report. The Journal of international medical research, 2022, Volume: 50, Issue:7 Topics: Aged; Amyloidosis; Benzoxazoles; Cardiomyopathies; Carvedilol; Humans; Male; Stroke Volume; Ventricular Function, Left	2022
Redefining Prognosis of Transthyretin Cardiomyopathy in the Tafamidis Era. Journal of cardiac failure, 2022, Volume: 28, Issue:10 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin; Prognosis	2022
Relationship of binding-site occupancy, transthyretin stabilisation and disease modification in patients with tafamidis-treated transthyretin amyloid cardiomyopathy. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2023, Volume: 30, Issue:2 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Disease Progression; Humans; Prealbumin	2023
Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2023, Volume: 30, Issue:3 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Humans; Prealbumin	2023
A Statement on the Appropriate Administration of Tafamidis in Patients With Transthyretin Cardiac Amyloidosis. Circulation journal : official journal of the Japanese Circulation Society, 2019, 12-25, Volume: 84, Issue:1 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Humans	2019
Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy. Drugs of today (Barcelona, Spain : 1998), 2019, Volume: 55, Issue:12 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Humans; Prealbumin	2019
In brief: Tafamidis (Vyndaqel; Vyndamax) for transthyretin amyloid cardiomyopathy. The Medical letter on drugs and therapeutics, 2020, Jan-27, Volume: 62, Issue:1590 Topics: Amyloid; Benzoxazoles; Cardiomyopathies; Drug Compounding; Drug Costs; Humans; Prealbumin; Randomized Controlled Trials as Topic; Treatment Outcome	2020
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy. Circulation, 2020, 04-14, Volume: 141, Issue:15 Topics: Aged; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Cost-Benefit Analysis; Female; Humans; Male; Quality of Life	2020
Willingness to Pay for High-Cost Medications. Circulation, 2020, 04-14, Volume: 141, Issue:15 Topics: Benzoxazoles; Cardiomyopathies; Cost-Benefit Analysis; Humans; Prealbumin	2020
Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2021, Volume: 28, Issue:1 Topics: Amyloid; Amyloid Neuropathies, Familial; Benzoates; Benzoxazoles; Cardiomyopathies; Diflunisal; Humans; Kinetics; Prealbumin; Protein Aggregates; Protein Binding; Protein Multimerization; Protein Subunits; Pyrazoles; Tolcapone	2021
JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis. Circulation journal : official journal of the Japanese Circulation Society, 2020, 08-25, Volume: 84, Issue:9 Topics: Amyloidosis; Benzoxazoles; Cardiomyopathies; Humans; Japan; Prognosis; Treatment Outcome	2020
Response by Kazi et al to Letter Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy". Circulation, 2020, 10-13, Volume: 142, Issue:15 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Cost-Benefit Analysis; Humans; Prealbumin	2020
Letter by Rozenbaum et al Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy". Circulation, 2020, 10-13, Volume: 142, Issue:15 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Cost-Benefit Analysis; Humans; Prealbumin	2020
Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'. European journal of heart failure, 2021, Volume: 23, Issue:4 Topics: Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin	2021
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT. JACC. Heart failure, 2021, Volume: 9, Issue:2 Topics: Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin	2021
Reply to the letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'. European journal of heart failure, 2021, Volume: 23, Issue:6 Topics: Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin	2021
Tafamidis Should Be Accessible for All Patients With Transthyretin Amyloid Cardiomyopathy. JACC. Heart failure, 2021, Volume: 9, Issue:2 Topics: Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin	2021
Tafamidis is entering the clinical arena for the treatment of transthyretin-related cardiomyopathy: certainties and unmet needs. European journal of heart failure, 2021, Volume: 23, Issue:2 Topics: Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin	2021
Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021, Volume: 21, Issue:5 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Hospitalization; Humans; Models, Statistical; Survival Analysis	2021
[What gnaws at the heart and gets on the nerves]. Der Internist, 2018, Volume: 59, Issue:11 Topics: Aged; Amyloid; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Drug Approval; Humans; Middle Aged; Mutation; Polyneuropathies; Prealbumin; Quality of Life	2018
Transthyretin Stabilizer Is Associated With Expanding Apical Sparing Area and Improving Global Cardiac Function in a Patient With Wild-Type Cardiac Amyloidosis. Circulation journal : official journal of the Japanese Circulation Society, 2019, 02-25, Volume: 83, Issue:3 Topics: Aged; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Heart; Humans; Magnetic Resonance Angiography; Male; Treatment Outcome	2019
Tafamidis: a new treatment for ATTR cardiomyopathy. Nature reviews. Cardiology, 2018, Volume: 15, Issue:11 Topics: Amyloidosis; Benzoxazoles; Cardiomyopathies; Humans; Prealbumin	2018
Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy. Arquivos de neuro-psiquiatria, 2018, Volume: 76, Issue:9 Topics: Amyloid Neuropathies, Familial; Animals; Benzoxazoles; Brazil; Cardiomyopathies; Diagnosis, Differential; Humans; Oligonucleotides; Randomized Controlled Trials as Topic; RNA, Small Interfering	2018
Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy. ESC heart failure, 2019, Volume: 6, Issue:1 Topics: Aged; Amyloid Neuropathies, Familial; Benzoxazoles; Biopsy; Cardiomyopathies; Electrocardiography; Follow-Up Studies; Humans; Magnetic Resonance Imaging, Cine; Male; Myocardium	2019
Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report. Journal of medical case reports, 2018, Dec-16, Volume: 12, Issue:1 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Diuretics; Echocardiography; Genes, Dominant; Humans; Male; Middle Aged; Mutation; Prealbumin; Radionuclide Imaging; Treatment Outcome	2018
Tafamidis for Transthyretin Amyloid Cardiomyopathy. The New England journal of medicine, 2019, 01-10, Volume: 380, Issue:2 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Humans; Prealbumin	2019
Tafamidis for Transthyretin Amyloid Cardiomyopathy. The New England journal of medicine, 2019, 01-10, Volume: 380, Issue:2 Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Humans; Prealbumin	2019
Real-world versus trial patients with transthyretin amyloid cardiomyopathy. European journal of heart failure, 2019, Volume: 21, Issue:11 Topics: Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Angiotensin-Converting Enzyme Inhibitors; Benzoxazoles; Cardiomyopathies; Cardiovascular Agents; Clinical Trials as Topic; Diuretics; Female; Humans; Male; Rare Diseases	2019
AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin. Proceedings of the National Academy of Sciences of the United States of America, 2013, Jun-11, Volume: 110, Issue:24 Topics: Amyloid; Amyloidosis; Animals; Area Under Curve; Benzoates; Benzoxazoles; Cardiomyopathies; Cell Line; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; HeLa Cells; Humans; MCF-7 Cells; Mice; Mice, Inbred ICR; Models, Molecular; Molecular Structure; Mutation; Prealbumin; Protein Binding; Protein Stability; Protein Structure, Tertiary; Pyrazoles; Rats; Rats, Wistar	2013
NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy. American journal of physiology. Heart and circulatory physiology, 2014, Sep-01, Volume: 307, Issue:5 Topics: Animals; Arrhythmias, Cardiac; Benzoxazoles; Calcium; Calcium Signaling; Cardiomyopathies; Membrane Glycoproteins; Mice; Mice, Inbred mdx; Myocardial Contraction; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type I; Oxidative Stress; Sarcoplasmic Reticulum; Triazoles	2014
Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy). Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2015, Volume: 22, Issue:3 Topics: Aged, 80 and over; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Drug Dosage Calculations; Drug Monitoring; Escherichia coli; Gene Expression; Humans; Kinetics; Male; Neuroprotective Agents; Prealbumin; Precision Medicine; Protein Stability; Recombinant Proteins	2015